» Articles » PMID: 39773362

Remimazolam for the Prevention of Emergence Agitation in Adults Following Nasal Surgery Under General Anesthesia: a Prospective Randomized Clinical Controlled Trial

Overview
Journal BMC Anesthesiol
Publisher Biomed Central
Specialty Anesthesiology
Date 2025 Jan 8
PMID 39773362
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Remimazolam is a novel intravenous sedative/anesthetic drug that belongs to the ultra-short-acting class of benzodiazepines. The purpose of this study was to evaluate the effectiveness of postoperative use of remimazolam in preventing emergence agitation (EA) in adults following nasal surgery.

Methods: Patients who underwent nasal surgery were randomly divided into Group R and Group C. Propofol, sufentanil, and cis-atracurium were used for the induction of anesthesia, and 1.5-3.5% sevoflurane was used for the maintenance of anesthesia. At the end of the surgery, patients were randomly assigned to receive either remimazolam 0.1 mg kg (Group R, n = 43) or 0.9% saline (Group C, n = 43). The primary outcome was the incidence of EA, which was defined as a Riker Sedation-Agitation Scale score > 4. The secondary outcomes included the incidence of severe EA, anesthesia, surgery characteristics, adverse events, mean arterial pressure, and heart rate (at different time points).

Results: A total of 86 adult patients completed the study. The incidence of EA was lower in Group R than in Group C (21% vs. 49%, P = 0.007). The incidence of severe EA was also lower in Group R than in Group C (2% vs. 19%, P = 0.035). The maximal Sedation-Agitation Scale score during emergence was lower in Group R 4 [range 4 to 4] than in Group C 5 [range 4 to 6] (P < 0.001). In addition, the incidence of hypertension and grade of cough in Group R were lower than in Group C (P = 0.024). During emergence, the mean arterial pressure and heart rate of group R showed more stability than those in group C.

Conclusions: Postoperative intravenous infusion of 0.1 mg/kg remimazolam into adult patients undergoing nasal surgery can reduce the incidence of EA and severe EA, and provide stable hemodynamics.

Trial Registration: The trial was registered, before patient enrollment, in the Chinese Clinical Trial Registry ( www.chictr.org.cn ) (clinical trial number: ChiCTR2300075300; Principal Investigator: Gongchen Duan; date of registration: 31 August 2023; https://www.chictr.org.cn/bin/project/edit?pid=203928 ).

References
1.
Amin S, Hasanin A, ElSayed O, Mostafa M, Khaled D, Arafa A . Comparison of the hemodynamic effects of opioid-based versus lidocaine-based induction of anesthesia with propofol in older adults: a randomized controlled trial. Anaesth Crit Care Pain Med. 2023; 42(4):101225. DOI: 10.1016/j.accpm.2023.101225. View

2.
Yang J, Lei L, Qiu D, Chen S, Xing L, Zhao J . Effect of Remimazolam on Postoperative Delirium in Older Adult Patients Undergoing Orthopedic Surgery: A Prospective Randomized Controlled Clinical Trial. Drug Des Devel Ther. 2023; 17:143-153. PMC: 9880012. DOI: 10.2147/DDDT.S392569. View

3.
Mo J, Han D, Shin H, Cha W, Chang M, Jin H . No packing versus packing after endoscopic sinus surgery: pursuit of patients' comfort after surgery. Am J Rhinol. 2008; 22(5):525-8. DOI: 10.2500/ajr.2008.22.3218. View

4.
Cho E, Yoon S, Cho J, Lee H . Comparison of the effects of 0.03 and 0.05 mg/kg midazolam with placebo on prevention of emergence agitation in children having strabismus surgery. Anesthesiology. 2014; 120(6):1354-61. DOI: 10.1097/ALN.0000000000000181. View

5.
Barreto A, Rangel da Rocha Paschoal A, Barbosa Farias C, Borges P, Andrade R, de Orange F . [Risk factors associated with anesthesia emergence delirium in children undergoing outpatient surgery]. Braz J Anesthesiol. 2017; 68(2):162-167. PMC: 9391807. DOI: 10.1016/j.bjan.2017.11.002. View